BIGG

The use of delamanid in the treatment of multidrug-resistant tuberculosis: interim policy guidance

World Health Organization.

The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...

Análisis Costo-Beneficio, Tuberculosis Resistente a Múltiples Medicamentos/tratamiento farmacológico, Quimioterapia Combinada, Nitroimidazoles/uso terapéutico, Resultado del Tratamiento, Antituberculosos/uso terapéutico, Tuberculosis Pulmonar/tratamiento farmacológico, Ensayos Clínicos como Asunto, Nitroimidazoles/economía, Antituberculosos/economía

Texto completo

Guidance for national tuberculosis programmes on the management of tuberculosis in children

This Guideline outlines the purpose and the target audience of the second edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children. It discusses the difference between TB in children and adolescents and TB in adults and provides an estimate of the burden of c...